Kenneth Oye, Political Scientist at the Massachusetts Institute of Technology. “Regulators should not require superior efficacy as a criterion for granting a licence to a drug. By approving equally ef...
We use cookies to improve your browsing experience, personalise content and analyse our traffic. Some cookies are necessary for the site to work and cannot be disabled. By accepting, you agree to our cookie policy. You can change your preferences at any time.